miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway.

Tung, S-L; Huang, W-C; Hsu, F-C; Yang, Z-P; Jang, T-H; Chang, J-W; Chuang, C-M; Lai, C-R; Wang, L-H

Tung, S-L; Huang, W-C; Hsu, F-C; Yang, Z-P; Jang, T-H; Chang, J-W; Chuang, C-M; Lai, C-R; Wang, L-H.

Afiliação

Tung SL; Institute of Molecular Medicine, National Tsing Hua University, Hsinchu, Taiwan.
Huang WC; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Hsu FC; Department of Hematology and Oncology, Ton-Yen General Hospital, Hsinchu, Taiwan.
Yang ZP; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Jang TH; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Chang JW; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Chuang CM; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Lai CR; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Wang LH; Institute of Clinical Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.

Oncogenesis ; 6(5): e326, 2017 May 01.

Article em En | MEDLINE | ID: mdl-28459431

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article